Uscom Ltd - Uscom Partners with A&D for BP+ New Advanced Modules.
Uscom Ltd (ASX:UCM)

Uscom Partners with A&D for BP+ New Advanced Modules.

Published Apr 30, 2020

What happened?


What's happened?

Uscom Limited (ASX:UCM) today announced the signing of a development and supply agreement with A&D Limited of Japan.

What are the key highlights?

  1. The agreement relates to new technology being installed in the patented protected Uscom BP+ central blood pressure monitor.
  2. This supply agreement comes as the BP+ approaches regulatory approval in China and the US, and as Uscom transitions to volume manufacturing to meet the anticipated increased BP+ demand. The A&D module will be included in all new BP+ devices.
  3. The BP+ advanced central blood pressure (BP) monitor and its stand alone software, the BP+ Reporter, provides new information to improve diagnosis and management of hypertension and vascular health.
  4. A&D (Analogue and Digital) are a Tokyo based multinational company engaged in the development, manufacture and sale of precision measurement instruments in the Industrial and Medical and Health care sector. A&D was founded in 1977, and reported an annual revenue of ~$600m AUD in 2018, of which approximately 1/3rd was from the Medical and Health care sector, and it was capitalised at a value of ~$15B AUD on the Tokyo Stock Exchange.

CEO's summary

Rob Phillips CEO of Uscom Ltd has provided a statement.
Rob Phillips
Rob Phillips
CEO, Uscom Ltd

"Current hypertensive management is poor, and we have developed the BP+ to advance the science in this common and dangerous condition. Quality technology is critical for our devices, and this new partnership with A&D, world leaders in medical measurements and instrumentation, allows Uscom to provide clinicians with the best tools for BP monitoring and hypertensive care. These technologic co-developments have been in testing for 12 months and are now central to the new BP+ devices. Uscom’s philosophy is that improved clinical care will be driven by the implementation of advanced life-saving medical devices, and this is why BP+ is important.”

Download Announcement

View this announcement as well as our full profile on the company.

Comments

Share your thoughts about this announcement...

Around the web
Closing Bell: Cettire rejects AFR claims, GDP’s gone back to the 90’s and ASX200 ends above the ice
Local markets end slightly higher IT Sector slumps 1.2pc Small Caps led by AT1   The ASX 200 trade...
via stockhead.com.au
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
via stockhead.com.au
Closing Bell: ASX unconvincing ahead of big CPI read and maiden address by new RBA boss
Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW...
via stockhead.com.au
Powered by  
  • Company
    Uscom Ltd
  • Website
  • Sector
    Health Care Equipment & Supplies
  • Industry
    Health Care Equipment
  • Code
    ASX:UCM
View Uscom Ltd's Profile

How do I invest?

Considering investing in Uscom Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:UCM

    On your online investment platform search for the stock ticker code ASX:UCM to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.

Up